Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biomarker discovery using protein microarray technology platforms: antibody-antigen complex profiling.

Dawn Mattoon1, Gregory Michaud, Janie Merkel

  • 1Invitrogen Corporation, ProtoArray Services, ProtoArray Center, 688 East Main Street, Branford, CT 06405, USA. dawn.mattoon@invitrogen.com

Expert Review of Proteomics
|November 26, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post Pacing Interval Following Failed Anti-Tachycardia Pacing Predicts Epicardial Ventricular Tachycardia Circuits in Patients With Non-Ischemic Cardiomyopathy.

Journal of cardiovascular electrophysiology·2026
Same author

Double Trouble: Sinus Node Dysfunction Masquerading as High-Grade AV Block.

JACC. Clinical electrophysiology·2026
Same author

Impact of Lesion Delivery and Irrigation Rates on Neurovascular Events With PFA for Atrial Fibrillation.

JACC. Clinical electrophysiology·2026
Same author

Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US.

Journal of the American College of Cardiology·2025
Same author

Fluoroless Mapping and Ablation With Integration of a Pentaspline Pulsed Field Catheter.

Journal of cardiovascular electrophysiology·2025
Same author

A call to action for an innovative and integrative approach to persistent atrial fibrillation: Perspectives from the Heart Rhythm Society Emerging Leaders Think Tank.

Heart rhythm·2025
Same journal

Unveiling the post translational modification code in Alzheimer's pathogenesis: crosstalk between phosphorylation and acetylation.

Expert review of proteomics·2026
Same journal

Plasma proteome profiles of standard-risk and high-risk childhood acute lymphoblastic leukemia.

Expert review of proteomics·2026
Same journal

Potential proteomic biomarkers for monitoring clinical studies in Duchenne/Becker muscular dystrophy.

Expert review of proteomics·2026
Same journal

Proteomics-based approaches to neutrophil biology.

Expert review of proteomics·2026
Same journal

Deciphering mitochondrial metabolic vulnerabilities in ovarian clear cell carcinoma with mass spectrometry-based clinical proteomics.

Expert review of proteomics·2026
Same journal

The proteomic origin of the genetic code.

Expert review of proteomics·2026
See all related articles

Protein microarrays are revolutionizing disease biomarker discovery. Antibody-based assays on these arrays help define immune responses for personalized medicine, improving diagnosis and treatment.

Area of Science:

  • Proteomics
  • Systems Biology
  • Immunology

Background:

  • Protein microarrays are emerging as powerful tools in systems biology.
  • Understanding immune responses is crucial for disease diagnostics.

Purpose of the Study:

  • To review the role of protein microarrays in discovering novel disease biomarkers.
  • To highlight the application of protein microarrays in immune response profiling.

Main Methods:

  • Review of antibody-based assays utilizing protein microarrays.
  • Analysis of immune repertoire profiling for disease-specific antibody identification.

Main Results:

  • Protein microarrays facilitate the discovery of novel disease biomarkers.

Related Experiment Videos

  • Immune response profiling using protein microarrays can define disease-specific antibody repertoires.

    • Conclusions:

    • Antigens and antibodies identified via protein microarrays are valuable for clinical assay development.
    • Biomarker discovery through protein microarrays supports personalized medicine, including diagnostics and targeted therapies.